Back
ESC Premium Access

The difference of long-term outcome by the anti-arrhythmic drug after pulmonary vein isolation for non-paroxysmal atrial fibrillation; sub-analysis of EAST-AF trial

Session: Poster Session 2 - Atrial fibrillation ablation
Topic: Rhythm Control, Catheter Ablation
Speaker: Doctor K. Kaitani (Otsu, JP)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Kazuaki Kaitani

Japanese Red Cross Otsu Hospital, Otsu (Japan)
1 presentation
0 follower

29 more presentations in this session

Terminating the induced atrial tachyarrhythmia after complete pulmonary vein isolation during catheter ablation for persistent atrial fibrillation

Speaker: Professor Y. Oh (Seoul, KR)

Access
Abstract
Slides
Like
Thumbnail

How long the duration of atrial fibrillation is associated with poor rhythm outcome after catheter ablation?

Speaker: Assistant Professor H. Yu (Seoul, KR)

Access
Abstract
Like
Thumbnail

Comparison of the efficacy of new-generation atrial antitachycardia pacing between patients with sick sinus syndrome and atrioventricular block

Speaker: Doctor S. Otuki (Osaka, JP)

Access
Abstract
Like
Thumbnail

Figure-of-eight stitch access site closure significantly reduces bleeding complications in patients undergoing cryoballoon ablation guided by intracardiac echocardiography

Speaker: Doctor V. Rubesch-Kuetemeyer (Detmold, DE)

Access
Abstract
Slides
Like
Thumbnail

Cryoballoon ablation of atrial fibrillation guided by high-resolution mapping: a multicentre study

Speaker: Professor G. Conte (Lugano, CH)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 2 - Atrial fibrillation ablation

Speakers: Doctor K. Kaitani, Professor Y. Oh, Assistant Professor H. Yu, Doctor S. Otuki, Doctor V. Rubesch-Kuetemeyer...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources